← Leaderboards
Christopher B Fox
Access To Advanced Health Institute
$4,575,361
Attributed
$4,575,361
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $856.6K · FY2014–22$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,575,361 · 2
By mechanism
R01$4,130,411 · 1
R21$444,950 · 1
Top collaborators
No co-investigators on record.
Most similar at Access To Advanced Health Institute
Same institution · by research overlap
- Mark Orr$638,034
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyVaccine EfficacyPropertyRouteTechnology DevelopmentVaccine AdjuvantInnovationOilsRecombinantsResearch InstituteInfectious Diseases ResearchImmune ResponseBaseUniversitiesAdjuvantCharacteristicsIn VitroMouse ModelEvaluationEmulsionsAntigensReportingImmunogenicityVaccines
Grant awards (7)
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions$786,095
R01 · FY2022 · AI · contact PI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions$833,113
R01 · FY2021 · AI · contact PI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions$848,166
R01 · FY2020 · AI · contact PI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions$856,636
R01 · FY2019 · AI · contact PI
Engineering sustainable squalene analogues for novel vaccine adjuvant emulsions$806,401
R01 · FY2018 · AI · contact PI
Nanoformulation of Synergistic TLR Ligands to Enhance Amebiasis Vaccine Efficacy$202,250
R21 · FY2015 · AI · contact PI
Nanoformulation of Synergistic TLR Ligands to Enhance Amebiasis Vaccine Efficacy$242,700
R21 · FY2014 · AI · contact PI